Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
Autori principali: | , , , , , , , , , , , , , , , , , |
---|---|
Natura: | Conference item |
Pubblicazione: |
American Thoracic Society
2017
|